CD19 and systemic lupus erythematosus: Our results demonstrate that CD19+CD24hiCD38hi B cell subsets possess a robust immune regulatory capacity to produce IL-10 in gastric cancer, which is consistent with a previous report in SLE and includes most CD5+CD1dhi B cells [21].